site stats

Biomarin pharmaceutical market cap

WebApr 9, 2024 · BioMarin Pharmaceutical Inc. has a 12-month low of $70.73 and a 12-month high of $117.77. The company has a market cap of $18.58 billion, a PE ratio of 134.59 and a beta of 0.38. The stock... WebApr 6, 2024 · About the company. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and …

BMRN Stock News BIOMARIN PHARMACEUTICAL Stock Price …

WebFind the latest BioMarin Pharmaceutical Inc. (BMRN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 18.394B: Beta (5Y ... Discover historical prices for BMRN stock on Yahoo Finance. View daily, weekly or … Find the latest BioMarin Pharmaceutical Inc. (BMRN) stock discussion in Yahoo … Interactive Chart for BioMarin Pharmaceutical Inc. (BMRN), analyze all … View the basic BMRN option chain and compare options of BioMarin … See BioMarin Pharmaceutical Inc. (BMRN) stock analyst estimates, including … See the company profile for BioMarin Pharmaceutical Inc. (BMRN) including … Find out the direct holders, institutional holders and mutual fund holders for … Find out all the key statistics for BioMarin Pharmaceutical Inc. (BMRN), including … See BioMarin Pharmaceutical Inc. (BMRN) Environment, Social and Governance … Get the detailed quarterly/annual income statement for BioMarin Pharmaceutical … WebApr 11, 2024 · The firm has a market capitalization of $18.29 billion, a P/E ratio of 132.50 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a fifty-two week low of $70.73 and a fifty-two week high... tags on linkedin posts https://paulasellsnaples.com

Strs Ohio Sells 12,959 Shares of BioMarin Pharmaceutical Inc.

Web24 rows · As of March 2024 BioMarin Pharmaceutical has a market cap of $16.71 Billion. This makes BioMarin Pharmaceutical the world's 978th most valuable company by market cap according to our data. The … WebApr 10, 2024 · Biomarin Pharmaceutical Inc.'s market capitalization is $18.49 B by 186.53 M shares outstanding. Is Biomarin Pharmaceutical stock a Buy, Sell or Hold? … WebOur data points out that BioMarin Pharmaceutical Inc. (BMRN) is ranked #820 out of 13000 companies on February - 2024. BMRN's Market Capitalization is $20.7 billion … tagus 18

BioMarin Pharmaceutical (BMRN) Stock Price & Analysis - TipRanks

Category:BioMarin Pharmaceutical (BMRN) Stock Price & Analysis - TipRanks

Tags:Biomarin pharmaceutical market cap

Biomarin pharmaceutical market cap

Strs Ohio Sells 12,959 Shares of BioMarin Pharmaceutical Inc.

WebDec 30, 2024 · Pharma giant Pfizer recently announced that it will acquire Arena Pharmaceuticals for $100 per share or a total equity value of approximately $6.7 billion to further expand its portfolio. Per... Web2 days ago · Technical analysis trends BIOMARIN PHARMACEUTICAL INC. Technical analysis Income Statement Evolution More Financials Consensus Consensus EPS Revisions More Estimates Revisions Managers and Directors More about the company Sector and Competitors More Results

Biomarin pharmaceutical market cap

Did you know?

WebView the latest BioMarin Pharmaceutical Inc. (BMRN) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebApr 10, 2024 · See the latest Biomarin Pharmaceutical Inc stock price (NASDAQ:BMRN), related news, valuation, dividends and more to help you make your investing decisions. …

WebAccording to BioMarin Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $2.09 B . In 2024 the company made a revenue of $1.84 B a decrease over the years 2024 revenue that were of $1.86 B .The revenue is the total amount of income that a company generates by the sale of goods or services. WebApr 13, 2024 · The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15.

WebBioMarin Pharmaceutical Symbol: BMRNRank: #820Price: $111.81(-0.9128%) Market Cap: $20.7B($-189.6M)Industry: BiotechnologySector: HealthcareCountry: United StatesInsiders: 0.552%Institutions: 101.394% BioMarin Pharmaceutical Inc. Technicals 52 Week High: $114.8 52 Week Low: $70.73 50 Day MA: $99.43 200 Day MA: $88.59 Web26 rows · Mar 22, 2024 · Biomarin Pharmaceutical Market Cap: 17.44B for March 29, 2024. Market Cap Chart. Historical Market Cap Data. View and export this data back to …

WebApr 12, 2024 · BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. The business has a 50 day simple moving average of $99.85 and a 200-day simple moving average of $98.40.

WebJan 22, 2024 · Market Cap. $19B. Today's Change (-1.56%) -$1.55. Current Price ... That's why I like BioMarin Pharmaceutical (BMRN-1.56%), a biotech company founded in … taguleleWebBioMarin Pharmaceutical market cap as of February 03, 2024 is $20.81B . BioMarin Pharmaceutical market cap history and chart from 2010 to 2024. Market capitalization … tagungshaus ostseeWebApr 13, 2024 · BioMarin Pharmaceutical Stock Performance NASDAQ:BMRN opened at $97.96 on Thursday. The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. The... tagus beerWebBioMarin Pharmaceutical (BMRN) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund … tagungshotels ostseeWebApr 9, 2024 · BioMarin Pharmaceutical Inc. has a 12-month low of $70.73 and a 12-month high of $117.77. The company has a market cap of $18.58 billion, a PE ratio of 134.59 and a beta of 0.38. The stock has a 50 day simple moving average of $100.53 and a 200-day simple moving average of $98.13. エボニー 嘘WebFeb 27, 2024 · BioMarin, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $537.54 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate... エボシ式 電WebApr 10, 2024 · BMRN Complete BioMarin Pharmaceutical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. … tagus street liverpool